Default object view. Click to create a custom template, Node ID: 134253, Object ID: 78979

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

No relation

Yes

No relation

No

06/01/2016 1:29 pm

No